News

Aspira Women's Health to Present at the MedInvest Biotech & Pharma Investor Conference

AUSTIN, Texas, March 21, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that management will present a corporate overview at the MedInvest Biotech & Pharma Investor Conference taking place in New York City on April 3-4, 2024. Management will be available for one-on-one meetings with investors who are registered for the conference.

03/21/2024

Aspira Women's Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024

AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that the Company will report its financial results for the three months and year ended December 31, 2023 on Thursday, March 28, 2024. Management will also host a conference call at 4:30 pm to discuss financial results and provide a corporate update. Details for the call are as follows:

03/11/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Aspira Women's Health Inc. (AWH) a buy, sell, or hold?

Aspira Women's Health Inc. (AWH) can sell. Click on Rating Page for detail.

What is Aspira Women's Health Inc.'s stock price?

The price of Aspira Women's Health Inc. (AWH) is 3.21 and it was updated on 2024-05-05 07:00:44.

Is Aspira Women's Health Inc. (AWH) overvalued or undervalued?

Currently Aspira Women's Health Inc. (AWH) is in undervalued.

News

From:

To:

News
Aspira Women's Health to Present at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference AUSTIN, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that management will present a corporate overview at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference taking place in New Orleans, Louisiana on February 29 to March 2, 2024. Management will be available for one-on-one meetings with investors who are registered for the conference. Thu, Feb. 22, 2024
Aspira Women's Health Inc. (AWH) Q3 2023 Earnings Call Transcript Aspira Women's Health Inc. (NASDAQ:AWH ) Q3 2023 Earnings Call November 13, 2023 4:30 PM ET Company Participants Nicole Sandford - President and Chief Executive Officer Torsten Hombeck - Chief Financial Officer Conference Call Participants Ben Haynor - Alliance Global Partners Operator Good afternoon, ladies and gentlemen, and welcome to the Aspira Women's Health Incorporated Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. Mon, Nov. 13, 2023
Aspira Women's Health to Present at the BioVenture Nexus Conference The conference is taking place on October 5-6, 2023, in Los Angeles, CA The conference is taking place on October 5-6, 2023, in Los Angeles, CA Fri, Sep. 29, 2023
Is Aspira Women's Health (AWH) Stock Outpacing Its Medical Peers This Year? Here is how Aspira (AWH) and Compugen (CGEN) have performed compared to their sector so far this year. Thu, Sep. 14, 2023
All You Need to Know About Aspira (AWH) Rating Upgrade to Buy Aspira (AWH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Tue, Sep. 12, 2023

Transcripts

Transcipts Data
Aspira Women's Health Inc. (AWH) on Q4 2023 Results - Earnings Call Transcript SA Transcripts Thu, Mar. 28, 2024
Aspira Women's Health Inc. (AWH) on Q3 2023 Results - Earnings Call Transcript SA Transcripts Mon, Nov. 13, 2023
Aspira Women's Health Inc. (AWH) on Q2 2023 Results - Earnings Call Transcript SA Transcripts Mon, Aug. 14, 2023
Aspira Women's Health Inc. (AWH) on Q1 2023 Results - Earnings Call Transcript SA Transcripts Thu, May. 11, 2023
Aspira Women's Health Inc. (AWH) on Q4 2022 Results - Earnings Call Transcript SA Transcripts Wed, Mar. 22, 2023
Aspira Women's Health Inc. (AWH) on Q3 2022 Results - Earnings Call Transcript SA Transcripts Thu, Nov. 10, 2022
Aspira Women's Health Inc. (AWH) on Q2 2022 Results - Earnings Call Transcript SA Transcripts Wed, Aug. 10, 2022
Aspira Women's Health Inc. (AWH) on Q1 2022 Results - Earnings Call Transcript SA Transcripts Wed, May. 11, 2022
Aspira Women's Health Inc. (AWH) on Q4 2021 Results - Earnings Call Transcript SA Transcripts Wed, Mar. 23, 2022
Aspira Women's Health Inc. (AWH) on Q3 2021 Results - Earnings Call Transcript SA Transcripts Wed, Nov. 10, 2021
Aspira Women's Health Inc. (AWH) on Q2 2021 Results - Earnings Call Transcript SA Transcripts Thu, Aug. 12, 2021
Aspira Women's Health Inc. (AWH) on Q1 2021 Results - Earnings Call Transcript SA Transcripts Thu, May. 13, 2021

SEC Filings

SEC Filings
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/26/2024
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 04/26/2024
Aspira Women's Health Inc. (AWH) - S-3 SEC Filings 04/22/2024
Aspira Women's Health Inc. (AWH) - 424B3 SEC Filings 04/11/2024
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 04/08/2024
Aspira Women's Health Inc. (AWH) - S-1 SEC Filings 04/05/2024
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 04/04/2024
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 04/01/2024
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 04/01/2024
Aspira Women's Health Inc. (AWH) - ARS SEC Filings 04/01/2024
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 04/01/2024
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/28/2024
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/25/2024
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/21/2024
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 02/20/2024
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 02/14/2024
Aspira Women's Health Inc. (AWH) - D SEC Filings 02/07/2024
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 01/30/2024
Aspira Women's Health Inc. (AWH) - S-8 SEC Filings 01/26/2024
Aspira Women's Health Inc. (AWH) - 8-K/A - Current report SEC Filings 01/26/2024
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 01/26/2024
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/25/2024
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/05/2024
Aspira Women's Health Inc. (AWH) - 4/A SEC Filings 12/29/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/27/2023
Aspira Women's Health Inc. (AWH) - 4/A SEC Filings 12/27/2023
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 12/26/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/08/2023
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 12/08/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/06/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/06/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/20/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/13/2023
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/13/2023
Aspira Women's Health Inc. (AWH) - 10-K/A - Current report SEC Filings 10/26/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/23/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/13/2023
Aspira Women's Health Inc. (AWH) - 4/A SEC Filings 09/29/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 09/13/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 09/12/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 09/12/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/30/2023
Aspira Women's Health Inc. (AWH) - 8-K/A - Current report SEC Filings 08/14/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/14/2023
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/14/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/09/2023
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 07/26/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/26/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/25/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/24/2023
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 07/24/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/24/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/20/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/14/2023
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 06/29/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/28/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/05/2023
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 06/05/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/02/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/02/2023
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 05/18/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/16/2023
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/15/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/11/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/10/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/28/2023
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 04/04/2023
Aspira Women's Health Inc. (AWH) - ARS SEC Filings 04/04/2023
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 03/30/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/30/2023
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/30/2023
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 03/29/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/22/2023
Aspira Women's Health Inc. (AWH) - PRE 14A SEC Filings 03/20/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/13/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/03/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/02/2023
Aspira Women's Health Inc. (AWH) - 4/A SEC Filings 02/21/2023
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/15/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 02/13/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/10/2023
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 02/10/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 02/10/2023
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 02/08/2023
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 02/08/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/07/2023
Aspira Women's Health Inc. (AWH) - 8-K/A - Current report SEC Filings 01/10/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/10/2023
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/09/2023
Aspira Women's Health Inc. (AWH) - PRER14A SEC Filings 12/28/2022
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 12/28/2022
Aspira Women's Health Inc. (AWH) - 8-K/A - Current report SEC Filings 12/22/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/21/2022
Aspira Women's Health Inc. (AWH) - PRE 14A SEC Filings 12/16/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/02/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/01/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/30/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/10/2022
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/10/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/01/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 10/03/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 09/01/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/30/2022
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 08/29/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/29/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/24/2022
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 08/24/2022
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 08/22/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/10/2022
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/10/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/01/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/12/2022
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 07/12/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/05/2022
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 07/05/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/27/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/27/2022
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 06/27/2022
Aspira Women's Health Inc. (AWH) - DEFR14A SEC Filings 06/07/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/07/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/06/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/02/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/01/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/18/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 05/18/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 05/17/2022
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 05/11/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/11/2022
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/11/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 05/03/2022
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 05/02/2022
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 04/29/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 04/04/2022
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/31/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/23/2022
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/01/2022
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 03/01/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/28/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/24/2022
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/16/2022
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 02/14/2022
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 01/13/2022
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/05/2022
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 12/30/2021
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 11/24/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/10/2021
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/10/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/04/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/03/2021
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 09/16/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/12/2021
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/12/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/23/2021
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/14/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/13/2021
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 05/10/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/10/2021
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 05/07/2021
Aspira Women's Health Inc. (AWH) - 10-K/A - Current report SEC Filings 04/30/2021
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/31/2021
Aspira Women's Health Inc. (AWH) - 8-K/A - Current report SEC Filings 03/26/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/25/2021
Aspira Women's Health Inc. (AWH) - 8-K/A - Current report SEC Filings 03/23/2021
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/23/2021
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 03/08/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/03/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/02/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/22/2021
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/11/2021
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 02/10/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/08/2021
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 02/05/2021
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 02/03/2021
Aspira Women's Health Inc. (AWH) - EFFECT SEC Filings 01/28/2021
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 01/26/2021
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 01/25/2021
Aspira Women's Health Inc. (AWH) - S-3 SEC Filings 01/20/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/06/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/05/2021
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/15/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/08/2020
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 11/19/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/12/2020
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/12/2020
Aspira Women's Health Inc. (AWH) - 424B3 SEC Filings 10/01/2020
Aspira Women's Health Inc. (AWH) - EFFECT SEC Filings 09/30/2020
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 09/25/2020
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 09/24/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 09/21/2020
Aspira Women's Health Inc. (AWH) - S-3 SEC Filings 09/18/2020
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 09/10/2020
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 08/19/2020
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/14/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/13/2020
Aspira Women's Health Inc. (AWH) - D SEC Filings 07/15/2020
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/09/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/07/2020
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 07/06/2020
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/06/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/29/2020
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 06/16/2020
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 06/12/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/11/2020
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/11/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/10/2020
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/10/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/09/2020
Aspira Women's Health Inc. (AWH) - 4/A SEC Filings 06/09/2020
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/09/2020
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/04/2020
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/02/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/14/2020
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/14/2020
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 05/11/2020
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 05/08/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/07/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/28/2020
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 04/27/2020
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 04/07/2020
Aspira Women's Health Inc. (AWH) - NT 10-K - Current report SEC Filings 03/31/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/26/2020
Aspira Women's Health Inc. (AWH) - 4/A SEC Filings 03/23/2020
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/23/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/17/2020
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/14/2020
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/31/2020
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/18/2019
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/12/2019
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/12/2019
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/15/2019
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/08/2019
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/08/2019
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/06/2019
Aspira Women's Health Inc. (AWH) - S-8 SEC Filings 07/03/2019
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 07/02/2019
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/02/2019
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/02/2019
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/01/2019
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/28/2019
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 06/27/2019
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 06/25/2019
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/24/2019
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/04/2019
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 05/17/2019
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/14/2019
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/14/2019
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 05/09/2019
Aspira Women's Health Inc. (AWH) - 10-K/A - Current report SEC Filings 04/29/2019
Aspira Women's Health Inc. (AWH) - 4/A SEC Filings 04/12/2019
Aspira Women's Health Inc. (AWH) - 4/A SEC Filings 04/08/2019
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/28/2019
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/28/2019
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/28/2019
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/11/2019
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 03/08/2019
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/06/2018
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/08/2018
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/08/2018
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/23/2018
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/21/2018
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/21/2018
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 08/21/2018
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/20/2018
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/17/2018
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/16/2018
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 08/10/2018
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/09/2018
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/09/2018
Aspira Women's Health Inc. (AWH) - S-8 SEC Filings 07/31/2018
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/26/2018
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/27/2018
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 06/25/2018
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/25/2018
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/30/2018
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/14/2018
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/14/2018
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 05/11/2018
Aspira Women's Health Inc. (AWH) - 10-K/A - Current report SEC Filings 04/30/2018
Aspira Women's Health Inc. (AWH) - PRE 14A SEC Filings 04/27/2018
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 04/23/2018
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 04/19/2018
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 04/19/2018
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/17/2018
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 04/17/2018
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 04/17/2018
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 04/16/2018
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 04/12/2018
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 04/03/2018
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/13/2018
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/13/2018
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/06/2018
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/13/2018
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/20/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/20/2017
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 12/20/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/16/2017
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/08/2017
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/08/2017
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 11/03/2017
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 10/31/2017
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/27/2017
Aspira Women's Health Inc. (AWH) - S-3 SEC Filings 10/24/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 10/18/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 09/18/2017
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 09/05/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 09/05/2017
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 09/01/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/31/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/30/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/29/2017
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/28/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/24/2017
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/11/2017
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/09/2017
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 08/04/2017
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 07/25/2017
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 06/29/2017
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/26/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 05/18/2017
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/11/2017
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/11/2017
Aspira Women's Health Inc. (AWH) - 424B3 SEC Filings 05/08/2017
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 05/01/2017
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 04/27/2017
Aspira Women's Health Inc. (AWH) - S-3 SEC Filings 04/11/2017
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/31/2017
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/29/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/27/2017
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/13/2017
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/03/2017
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 02/22/2017
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 02/17/2017
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/17/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 02/17/2017
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 02/15/2017
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/14/2017
Aspira Women's Health Inc. (AWH) - 8-K/A - Current report SEC Filings 01/09/2017
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/06/2017
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/10/2016
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/10/2016
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/03/2016
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/03/2016
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/10/2016
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/10/2016
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/22/2016
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/20/2016
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/16/2016
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/16/2016
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 04/29/2016
Aspira Women's Health Inc. (AWH) - 4/A SEC Filings 04/19/2016
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/30/2016
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/28/2016
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/24/2016
Aspira Women's Health Inc. (AWH) - 8-K/A - Current report SEC Filings 03/21/2016
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/21/2016
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/21/2016
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/25/2016
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/12/2016
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 02/01/2016
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 01/28/2016
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 01/26/2016
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 01/22/2016
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 01/20/2016
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/11/2016
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/04/2016
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/12/2015
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/12/2015
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/13/2015
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/13/2015
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 08/10/2015
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 08/03/2015
Aspira Women's Health Inc. (AWH) - S-8 SEC Filings 07/24/2015
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 07/21/2015
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/21/2015
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 07/17/2015
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/17/2015
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/16/2015
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/15/2015
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 07/14/2015
Aspira Women's Health Inc. (AWH) - 424B5 SEC Filings 07/13/2015
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/08/2015
Aspira Women's Health Inc. (AWH) - CT ORDER SEC Filings 06/25/2015
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/22/2015
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/22/2015
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/18/2015
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/14/2015
Aspira Women's Health Inc. (AWH) - 424B3 SEC Filings 05/13/2015
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/12/2015
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 05/11/2015
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/11/2015
Aspira Women's Health Inc. (AWH) - S-3/A SEC Filings 05/08/2015
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 04/29/2015
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 04/28/2015
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 04/24/2015
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/06/2015
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 04/02/2015
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/31/2015
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/25/2015
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 03/23/2015
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/23/2015
Aspira Women's Health Inc. (AWH) - 3/A SEC Filings 03/23/2015
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/20/2015
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/17/2015
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 02/19/2015
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 02/18/2015
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 02/11/2015
Aspira Women's Health Inc. (AWH) - S-3 SEC Filings 02/11/2015
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 02/11/2015
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 02/11/2015
Aspira Women's Health Inc. (AWH) - 5 SEC Filings 02/06/2015
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 01/22/2015
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 01/20/2015
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/13/2015
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/12/2015
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 01/05/2015
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 12/29/2014
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/29/2014
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 12/24/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/24/2014
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/23/2014
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 12/19/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/17/2014
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/03/2014
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/25/2014
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/21/2014
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/20/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/13/2014
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/13/2014
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 10/30/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/28/2014
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 10/27/2014
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 10/27/2014
Aspira Women's Health Inc. (AWH) - S-3/A SEC Filings 10/01/2014
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 09/24/2014
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 09/24/2014
Aspira Women's Health Inc. (AWH) - S-3 SEC Filings 09/15/2014
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 09/09/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/21/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/15/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/14/2014
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/14/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/28/2014
Aspira Women's Health Inc. (AWH) - 4/A SEC Filings 07/28/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/24/2014
Aspira Women's Health Inc. (AWH) - 8-K/A - Current report SEC Filings 05/16/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/15/2014
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/15/2014
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 04/29/2014
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 04/24/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/23/2014
Aspira Women's Health Inc. (AWH) - PRE 14A SEC Filings 04/18/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/18/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/15/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/07/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/31/2014
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/31/2014
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/31/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/10/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/06/2014
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 01/23/2014
Aspira Women's Health Inc. (AWH) - S-8 SEC Filings 01/10/2014
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/03/2014
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 12/23/2013
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/23/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/20/2013
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 12/20/2013
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/18/2013
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 12/18/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/17/2013
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/16/2013
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 12/05/2013
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/22/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/14/2013
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/14/2013
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 11/12/2013
Aspira Women's Health Inc. (AWH) - PRE 14A SEC Filings 11/01/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/01/2013
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 09/18/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 09/16/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/26/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/14/2013
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/14/2013
Aspira Women's Health Inc. (AWH) - S-3 SEC Filings 07/12/2013
Aspira Women's Health Inc. (AWH) - SC 13D SEC Filings 06/21/2013
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 06/13/2013
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/12/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/31/2013
Aspira Women's Health Inc. (AWH) - D SEC Filings 05/24/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/24/2013
Aspira Women's Health Inc. (AWH) - SC 13D SEC Filings 05/23/2013
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 05/23/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/15/2013
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/15/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/14/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/10/2013
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 04/01/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/26/2013
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/25/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/20/2013
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 03/20/2013
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 03/19/2013
Aspira Women's Health Inc. (AWH) - DFAN14A SEC Filings 03/18/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/13/2013
Aspira Women's Health Inc. (AWH) - DFAN14A SEC Filings 03/11/2013
Aspira Women's Health Inc. (AWH) - ARS SEC Filings 03/04/2013
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 03/01/2013
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/01/2013
Aspira Women's Health Inc. (AWH) - DFAN14A SEC Filings 02/26/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/26/2013
Aspira Women's Health Inc. (AWH) - DFAN14A SEC Filings 02/21/2013
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 02/21/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/20/2013
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 02/11/2013
Aspira Women's Health Inc. (AWH) - DFAN14A SEC Filings 02/01/2013
Aspira Women's Health Inc. (AWH) - ARS SEC Filings 02/01/2013
Aspira Women's Health Inc. (AWH) - DEFN14A SEC Filings 01/29/2013
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 01/29/2013
Aspira Women's Health Inc. (AWH) - PRRN14A SEC Filings 01/28/2013
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 01/28/2013
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 01/25/2013
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 01/23/2013
Aspira Women's Health Inc. (AWH) - PRER14A SEC Filings 01/18/2013
Aspira Women's Health Inc. (AWH) - DFAN14A SEC Filings 01/10/2013
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/07/2013
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 12/20/2012
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/14/2012
Aspira Women's Health Inc. (AWH) - PREN14A SEC Filings 12/12/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/11/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/28/2012
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/28/2012
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 11/20/2012
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 11/19/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/19/2012
Aspira Women's Health Inc. (AWH) - DFAN14A SEC Filings 11/16/2012
Aspira Women's Health Inc. (AWH) - DFAN14A SEC Filings 11/13/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/13/2012
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/13/2012
Aspira Women's Health Inc. (AWH) - DFAN14A SEC Filings 10/22/2012
Aspira Women's Health Inc. (AWH) - DFAN14A SEC Filings 10/16/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/12/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/14/2012
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/14/2012
Aspira Women's Health Inc. (AWH) - 10-K/A - Current report SEC Filings 05/30/2012
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 05/29/2012
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 05/25/2012
Aspira Women's Health Inc. (AWH) - PRRN14A SEC Filings 05/23/2012
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 05/22/2012
Aspira Women's Health Inc. (AWH) - PRRN14A SEC Filings 05/21/2012
Aspira Women's Health Inc. (AWH) - PRER14A SEC Filings 05/17/2012
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 05/17/2012
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 05/16/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/16/2012
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/15/2012
Aspira Women's Health Inc. (AWH) - PRER14A SEC Filings 05/09/2012
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 05/08/2012
Aspira Women's Health Inc. (AWH) - PRRN14A SEC Filings 05/08/2012
Aspira Women's Health Inc. (AWH) - PRRN14A SEC Filings 05/04/2012
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 05/04/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/04/2012
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 05/03/2012
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 05/02/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/30/2012
Aspira Women's Health Inc. (AWH) - 10-K/A - Current report SEC Filings 04/27/2012
Aspira Women's Health Inc. (AWH) - PREC14A SEC Filings 04/25/2012
Aspira Women's Health Inc. (AWH) - PREN14A SEC Filings 04/20/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/10/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/28/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/27/2012
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/27/2012
Aspira Women's Health Inc. (AWH) - 4/A SEC Filings 03/26/2012
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/23/2012
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 03/15/2012
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 03/15/2012
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 03/08/2012
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 03/07/2012
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 03/02/2012
Aspira Women's Health Inc. (AWH) - DFAN14A SEC Filings 02/29/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/23/2012
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/14/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/14/2012
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/10/2012
Aspira Women's Health Inc. (AWH) - CT ORDER SEC Filings 02/08/2012
Aspira Women's Health Inc. (AWH) - 10-Q/A - Quarterly Report SEC Filings 01/17/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/05/2012
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/22/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/20/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/17/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/16/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/15/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/14/2011
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 11/10/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/10/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/09/2011
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/09/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/02/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/02/2011
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 10/12/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/11/2011
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 10/11/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/03/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 10/03/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 09/26/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 09/15/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 09/01/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/12/2011
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/09/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/04/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/02/2011
Aspira Women's Health Inc. (AWH) - CT ORDER SEC Filings 07/11/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/06/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/09/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/08/2011
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 06/06/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/06/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/02/2011
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 05/27/2011
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 05/26/2011
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 05/20/2011
Aspira Women's Health Inc. (AWH) - DEFA14A SEC Filings 05/20/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/20/2011
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 05/20/2011
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 05/19/2011
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 05/13/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/10/2011
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/10/2011
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 04/29/2011
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 04/28/2011
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 04/21/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/20/2011
Aspira Women's Health Inc. (AWH) - SC 13D SEC Filings 04/18/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/24/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/22/2011
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/22/2011
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 02/28/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/16/2011
Aspira Women's Health Inc. (AWH) - 424B4 SEC Filings 02/15/2011
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/14/2011
Aspira Women's Health Inc. (AWH) - S-1/A SEC Filings 02/11/2011
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 02/11/2011
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/10/2011
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 02/10/2011
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/10/2011
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 02/04/2011
Aspira Women's Health Inc. (AWH) - S-1/A SEC Filings 02/02/2011
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 01/28/2011
Aspira Women's Health Inc. (AWH) - S-1 SEC Filings 01/21/2011
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 01/06/2011
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 12/17/2010
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/16/2010
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 12/14/2010
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 12/10/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/07/2010
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 11/24/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/12/2010
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/12/2010
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 10/20/2010
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 10/01/2010
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 10/01/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 09/30/2010
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 09/09/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/27/2010
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/26/2010
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/16/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/12/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/23/2010
Aspira Women's Health Inc. (AWH) - CERTNAS SEC Filings 07/06/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/06/2010
Aspira Women's Health Inc. (AWH) - 8-A12B SEC Filings 07/06/2010
Aspira Women's Health Inc. (AWH) - S-8 SEC Filings 05/28/2010
Aspira Women's Health Inc. (AWH) - 10-Q/A - Quarterly Report SEC Filings 05/28/2010
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 05/26/2010
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/24/2010
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 05/21/2010
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/20/2010
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 05/20/2010
Aspira Women's Health Inc. (AWH) - NT 10-Q - Quarterly Report SEC Filings 05/17/2010
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 04/23/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/22/2010
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 04/22/2010
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 04/21/2010
Aspira Women's Health Inc. (AWH) - NT 10-K - Current report SEC Filings 03/31/2010
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 03/23/2010
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 03/23/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/04/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/22/2010
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/17/2010
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/16/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/12/2010
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/03/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/03/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/25/2010
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 01/21/2010
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 01/12/2010
Aspira Women's Health Inc. (AWH) - D SEC Filings 01/12/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/12/2010
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/29/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/24/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/18/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/15/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/09/2009
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 12/04/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/04/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/25/2009
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 10/27/2009
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 10/27/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/23/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/21/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/09/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/05/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/02/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 09/30/2009
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 09/25/2009
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 09/24/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 09/15/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/24/2009
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 08/10/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/24/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/26/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/16/2009
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 06/04/2009
Aspira Women's Health Inc. (AWH) - S-8 POS SEC Filings 04/13/2009
Aspira Women's Health Inc. (AWH) - NT 10-K - Current report SEC Filings 04/01/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/31/2009
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/24/2009
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/13/2009
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/12/2009
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/10/2009
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 01/29/2009
Aspira Women's Health Inc. (AWH) - POS AM SEC Filings 12/31/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/17/2008
Aspira Women's Health Inc. (AWH) - 25-NSE SEC Filings 12/05/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/01/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/19/2008
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/14/2008
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/05/2008
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 10/30/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 09/26/2008
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 09/05/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/29/2008
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/22/2008
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 08/22/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/14/2008
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/14/2008
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/22/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/30/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/13/2008
Aspira Women's Health Inc. (AWH) - 4/A SEC Filings 06/13/2008
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/13/2008
Aspira Women's Health Inc. (AWH) - 424B3 SEC Filings 05/29/2008
Aspira Women's Health Inc. (AWH) - POS AM SEC Filings 05/23/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/15/2008
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/15/2008
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 05/14/2008
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 04/24/2008
Aspira Women's Health Inc. (AWH) - 424B3 SEC Filings 04/18/2008
Aspira Women's Health Inc. (AWH) - POS AM SEC Filings 04/17/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/17/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/11/2008
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 04/11/2008
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 04/11/2008
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 04/10/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/31/2008
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/31/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/05/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/03/2008
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/27/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/27/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/21/2008
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/14/2008
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/13/2008
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 02/06/2008
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 01/15/2008
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/11/2008
Aspira Women's Health Inc. (AWH) - PRE 14A SEC Filings 01/04/2008
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 12/14/2007
Aspira Women's Health Inc. (AWH) - 424B3 SEC Filings 12/14/2007
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 12/12/2007
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 12/12/2007
Aspira Women's Health Inc. (AWH) - S-1/A SEC Filings 12/06/2007
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 11/30/2007
Aspira Women's Health Inc. (AWH) - S-1/A SEC Filings 11/27/2007
Aspira Women's Health Inc. (AWH) - 3/A SEC Filings 11/26/2007
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/14/2007
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 11/13/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/13/2007
Aspira Women's Health Inc. (AWH) - 3/A SEC Filings 11/13/2007
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 11/13/2007
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 11/09/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/05/2007
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 10/30/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/26/2007
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 10/10/2007
Aspira Women's Health Inc. (AWH) - CORRESP SEC Filings 10/05/2007
Aspira Women's Health Inc. (AWH) - S-1 SEC Filings 09/27/2007
Aspira Women's Health Inc. (AWH) - UPLOAD SEC Filings 09/24/2007
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 09/18/2007
Aspira Women's Health Inc. (AWH) - REGDEX SEC Filings 09/17/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 09/17/2007
Aspira Women's Health Inc. (AWH) - REGDEX SEC Filings 09/14/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 09/12/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 09/07/2007
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 09/05/2007
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 09/04/2007
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 09/04/2007
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/30/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/29/2007
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 08/28/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/17/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/13/2007
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/13/2007
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 07/27/2007
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 07/24/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/17/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/12/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 07/06/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/16/2007
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 05/15/2007
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/15/2007
Aspira Women's Health Inc. (AWH) - 10-K/A - Current report SEC Filings 05/04/2007
Aspira Women's Health Inc. (AWH) - 10-K/A - Current report SEC Filings 04/30/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/11/2007
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 04/02/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/23/2007
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/14/2007
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/13/2007
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 02/13/2007
Aspira Women's Health Inc. (AWH) - 424B3 SEC Filings 01/22/2007
Aspira Women's Health Inc. (AWH) - S-3/A SEC Filings 01/17/2007
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/11/2007
Aspira Women's Health Inc. (AWH) - S-3 SEC Filings 12/15/2006
Aspira Women's Health Inc. (AWH) - 8-K/A - Current report SEC Filings 12/15/2006
Aspira Women's Health Inc. (AWH) - REGDEX SEC Filings 11/30/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/21/2006
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/21/2006
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 11/20/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/16/2006
Aspira Women's Health Inc. (AWH) - NT 10-Q - Quarterly Report SEC Filings 11/14/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/14/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/07/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/06/2006
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 11/06/2006
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 11/06/2006
Aspira Women's Health Inc. (AWH) - DEFM14A SEC Filings 09/28/2006
Aspira Women's Health Inc. (AWH) - PREM14A SEC Filings 09/12/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/25/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/18/2006
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 08/16/2006
Aspira Women's Health Inc. (AWH) - NT 10-Q - Quarterly Report SEC Filings 08/15/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/14/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/30/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 06/13/2006
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 06/09/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/31/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/26/2006
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 05/15/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 05/04/2006
Aspira Women's Health Inc. (AWH) - DEF 14A SEC Filings 04/28/2006
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 04/21/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 04/18/2006
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 04/14/2006
Aspira Women's Health Inc. (AWH) - 3 SEC Filings 04/14/2006
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 04/10/2006
Aspira Women's Health Inc. (AWH) - S-8 SEC Filings 04/06/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 03/23/2006
Aspira Women's Health Inc. (AWH) - 10-K - Current report SEC Filings 03/17/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 02/16/2006
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/15/2006
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 02/14/2006
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 02/14/2006
Aspira Women's Health Inc. (AWH) - 4 SEC Filings 02/14/2006
Aspira Women's Health Inc. (AWH) - SC 13G SEC Filings 02/09/2006
Aspira Women's Health Inc. (AWH) - SC 13D/A SEC Filings 01/19/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/13/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 01/06/2006
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/28/2005
Aspira Women's Health Inc. (AWH) - 10-Q/A - Quarterly Report SEC Filings 12/21/2005
Aspira Women's Health Inc. (AWH) - 10-Q - Quarterly Report SEC Filings 12/21/2005
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 12/07/2005
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/16/2005
Aspira Women's Health Inc. (AWH) - NT 10-Q - Quarterly Report SEC Filings 11/07/2005
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 11/07/2005
Aspira Women's Health Inc. (AWH) - SC 13G/A SEC Filings 10/25/2005
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 10/04/2005
Aspira Women's Health Inc. (AWH) - 8-K - Current report SEC Filings 08/11/2005

Press Releases

StockPrice Release
Aspira women's health announces anthem blue cross to provide coverage for ovasuite(sm) in california 04/09/2024
Aspira women's health reports fourth quarter and full year 2023 financial results 03/28/2024
Aspira women's health to present at the medinvest biotech & pharma investor conference 03/21/2024
Aspira women's health to announce fourth quarter and 2023 year end earnings results and host a conference call on thursday, march 28, 2024 03/11/2024
Aspira women's health to present at the cancer advocacy group of louisiana's 3rd annual neauxcancer conference 02/22/2024
Aspira women's health announces late-breaking poster presentation at the upcoming 71st annual scientific meeting for the society for reproductive investigation (sri) 02/12/2024
Aspira women's health to host r&d day with updates on the development of the company's ovarian cancer and endometriosis tests on january 4, 2024 12/19/2023
Aspira women's health to participate in corporate access events during jp morgan healthcare conference week 2024 12/14/2023
Aspira women's health provides a development update on its portfolio of noninvasive tests for endometriosis 12/06/2023
Aspira women's health secures reimbursement for ova1plus(r) from california medicaid (medi-cal) 11/28/2023
Aspira women's health receives final crosswalk pricing determination from the centers for medicare & medicaid services (cms) 11/27/2023
Aspira women's health supports centers for medicare & medicaid services (cms) proposed rule to crosswalk medicare reimbursement rate for ovawatch 11/09/2023
Aspira women's health sees poster on its mirna-based ovarian cancer test presented at the aacr special conference in cancer research 10/25/2023
Aspira women's health to present at the bioventure nexus conference 09/29/2023
Aspira women's health signs exclusive sample procurement agreement with the university of oxford 08/31/2023
Aspira women's health announces michelle snider as senior vice president, commercial strategy and operations 08/28/2023
Aspira women's health® reports second quarter 2023 financial results 08/14/2023
Aspira women's health announces transition of its chief scientific officer/chief operating officer 08/09/2023
Aspira women's health to announce second quarter earnings results and host a conference call on monday, august 14, 2023 07/31/2023
Aspira women's health regained compliance with nasdaq's minimum bid price requirement 06/02/2023
Aspira women's health announces the publication of three abstracts by the american society of clinical oncology (asco) supporting the clinical utility of ovasuite(sm) ovarian cancer risk assessment tests 05/31/2023
Aspira women's health to participate at william blair's 43rd annual growth stock conference 05/30/2023
Aspira women's health to present at the 2023 american college of obstetricians and gynecologists annual clinical & scientific conference 05/19/2023
Aspira women's health announces 1-for-15 reverse stock split 05/11/2023
Aspira women's health announces preliminary first quarter 2023 ovasuite volume increase of 29% and plans to announce full earnings results on may 11, 2023 04/27/2023
Aspira women's health reports fourth quarter and full year 2022 financial results 03/22/2023
Aspira women's health to announce year end 2022 financial results and host conference call on march 22, 2023 03/03/2023
Aspira women's health announces national payer coverage for ovawatch 03/03/2023
Aspira women's health announces publication of real-world data validating use of ovawatch for the management of adnexal masses 01/06/2023
Aspira women's health announces three reimbursement milestones that improve patient access to its ovasuite sm testing portfolio 12/27/2022
Aspira women's health reports third quarter 2022 financial results 11/10/2022
Aspira women's health to participate at the upcoming microcap rodeo windy city roundup 2022 10/06/2022
Aspira women's health announces publication of its second-generation multivariate index assay, overa®, in the detection of cancer in filipino women 09/12/2022
Aspira women's health inc. announces proposed public offering 08/22/2022
Aspira women's health hosting women's health webinar on ovarian cancer risk assessments utilizing multivariant index assay 08/18/2022
Aspira women's health reports second quarter 2022 financial results 08/10/2022
Aspira women's health announces appointment of two new board members 06/23/2022
Aspira women's health announces publication of paper validating ovawatch™ algorithm in the detection of ovarian cancer 06/16/2022
Aspira women's health reports first quarter 2022 financial results 05/11/2022
Aspira women's health to announce first quarter 2022 financial results and host conference call on wednesday, may 11 04/29/2022
Aspira women's health reports fourth quarter and full year 2021 financial results 03/23/2022
Aspira women's health to announce year end 2021 financial results and host conference call on wednesday, march 23 03/15/2022
Aspira women's health announces appointment of celeste fralick, ph.d., to its board of directors 02/28/2022
Aspira women's health, inc. expands senior leadership team with addition of mr. michael newton as head of sales and marketing 02/22/2022
Aspira women's health to participate in the upcoming winter wonderland best ideas conference 02/08/2022
Aspira women's health announces the addition of 465,000 covered lives through medicaid credentialing 01/31/2022
Aspira women's health reports third quarter 2021 financial results 11/10/2021
Aspira women's health executes four aspira synergytm technology transfer agreements 09/29/2021
Aspira women's health inc. to present at the cantor fitzgerald virtual global healthcare conference 09/21/2021
Aspira women's health kicks off ovarian cancer awareness month by further establishing itself as a thought leader in ovarian cancer 09/09/2021
Update -- aspira women's health inc. announces coverage for ova1® in the aim specialty health laboratory medicine clinical guidelines 07/08/2021
Aspira women's health inc. to participate in the william blair growth stock conference 05/19/2021
Aspira women's health reports first quarter 2021 financial results 05/13/2021
Aspira women's health, inc. expands leadership team with industry veteran 05/11/2021
Aspira women's health reports fourth quarter and full year 2020 financial results 03/25/2021
Aspira women's health inc. appoints nicole sandford to its board of directors 02/22/2021
Aspira women's health, inc. to participate in btig's virtual medtech, digital health, life science and diagnostic tools conference 02/12/2021
Aspira women's health, inc. to add nccn management recommendations to its proprietary aspira genetix™ clinical report 02/10/2021
Aspira women's health inc. announces pricing of $45 million public offering of common stock 02/04/2021
Aspira women's health inc. announces proposed public offering of common stock 02/03/2021
Aspira women's health, inc. to participate in virtual investor events 01/04/2021
Covid-19 recovery analysis: spa market \| growing wellness tourism industry to boost the market growth \| technavio 10/21/2020
Aspira women's health files for secondary offering of up to 3.2 mln shares 09/18/2020
Aspira women's health reports q2 loss per share of $0.04 08/13/2020
Vermillion posts quarterly net loss per share $0.04 05/14/2020
Vermillion inc - qtrly loss per share $0.03 03/26/2020
Vermillion reports third quarter 2019 financial results 11/12/2019
Allied world schedules third quarter 2016 earnings announcement and conference call 10/04/2016
Allied world schedules second quarter 2016 earnings announcement and conference call 06/28/2016
Allied world schedules first quarter 2016 earnings announcement and conference call 03/24/2016
Allied world schedules fourth quarter 2015 earnings announcement and conference call 01/08/2016
Allied world schedules third quarter 2015 earnings announcement and conference call 09/14/2015
Allied world schedules second quarter 2015 earnings announcement and conference call 06/18/2015
Allied world schedules first quarter 2015 earnings announcement and conference call 03/24/2015
Allied world schedules fourth quarter 2014 earnings announcement and conference call 01/06/2015
Allied world schedules third quarter 2014 earnings announcement and conference call 09/16/2014
Allied world to acquire the hong kong and singapore operations of rsa, significantly expanding international insurance platform 08/21/2014
Allied world schedules second quarter 2014 earnings announcement and conference call 06/24/2014
Allied world schedules first quarter 2014 earnings announcement and conference call 03/31/2014
Allied world schedules fourth quarter 2013 earnings announcement and conference call 01/06/2014

More Headlines

News
Eleventh-Hour Climbers: 7 Stocks Gearing Up for a Late Summer Surge While some publicly traded enterprises left no doubt as to their trajectory, a few others are just now benefiting from a late summer stock surge. Better late than never, though. 09/03/2023
Aspira Women's Health Inc. (AWH) Q2 2023 Earnings Call Transcript Aspira Women's Health Inc. (NASDAQ:AWH ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Nicole Sandford – President and Chief Executive Officer Torsten Hombeck – Chief Financial Officer Conference Call Participants Sally Yanchus – Water Tower Research Andrew Brackmann – William Blair Operator Good afternoon, ladies and gentlemen, and welcome to Aspira's Women's Health, Incorporated Second Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode. 08/14/2023
Aspira Women's Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023 AUSTIN, Texas, July 31, 2023 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira”), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that the company will report its financial results for the three months ended June 30, 2023 on Monday, August 14, 2023. Management will host a conference call to discuss financial results and provide a corporate update at 4:30 pm Eastern Time. Details for the call are as follows: 07/31/2023
Aspira Women's Health to Present at the 2023 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Conference AUSTIN, Texas, May 19, 2023 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced it would present at the upcoming 2023 American College of Obstetricians and Gynecologists (“ACOG”) Annual Clinical & Scientific Conference being held in Baltimore, MD on May 19-21, 2023. 05/19/2023
Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates Aspira (AWH) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.08 per share a year ago. 05/11/2023
New Strong Buy Stocks for May 11th AMEH, PYCR, AWH, SAND and MCD have been added to the Zacks Rank #1 (Strong Buy) List on May 11, 2023. 05/11/2023
Aspira Women's Health Announces Preliminary First Quarter 2023 OvaSuite Volume Increase of 29% and Plans to Announce Full Earnings Results on May 11, 2023 Preliminary first quarter 2023 volume was 6,259 tests, an increase of 29% compared to last year, the highest volume quarter in the company's history 04/27/2023
What Makes Aspira (AWH) a New Buy Stock Aspira (AWH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). 03/27/2023
Aspira Women's Health Inc. (AWH) Q4 2022 Earnings Call Transcript Aspira Women's Health Inc. (NASDAQ:AWH ) Q4 2022 Earnings Conference Call March 22, 2023 4:30 PM ET Company Participants Nicole Sandford - President & Chief Executive Officer Ryan Phan - Chief Scientific Officer & Chief Operating Officer Marlene McLennan - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Griffin Soriano - William Blair Operator Good morning ladies and gentlemen and welcome to Aspira Women's Health, Inc. Fourth Quarter and Year-End 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. 03/22/2023
Aspira (AWH) Reports Q4 Loss, Misses Revenue Estimates Aspira (AWH) delivered earnings and revenue surprises of 33.33% and 10.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? 03/22/2023
Aspira Women's Health to Announce Year End 2022 Financial Results and Host Conference Call on March 22, 2023 AUSTIN, Texas, March 03, 2023 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH), a bio-analytical based women's health company focused on gynecologic disease, today announced that the company will report its financial results for the year ended December 31, 2022 after the market closes on Wednesday, March 22, 2023. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time. Details for the call are below: 03/03/2023
Aspira Women's Health Inc. (AWH) Q3 2022 Earnings Call Transcript Aspira Women's Health Inc. (NASDAQ:AWH ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Nicole Sandford - President and Chief Executive Officer Ryan Phan - Chief Scientific Officer and Chief Operating Officer Robert Beechey - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Griffin Soriano - William Blair & Company Operator Good morning, ladies and gentlemen, and welcome to Aspira Women's Health Incorporated Third Quarter 2022 Conference Call. My name is David, and I will be your coordinator for the call today. 11/10/2022
Down 38.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Aspira (AWH) The heavy selling pressure might have exhausted for Aspira (AWH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal. 08/24/2022
Aspira Women's Health, Inc. (AWH) CEO Nicole Sandford on Q2 2022 Results - Earnings Call Transcript Aspira Women's Health, Inc. (NASDAQ:AWH ) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ET Company Participants Nicole Sandford - President and Chief Executive Officer Robert Beechey - Chief Financial Officer Ryan Phan - Chief Scientific Officer and Chief Operating Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Operator Good morning, ladies and gentlemen and welcome to Aspira Women's Health Inc. Second Quarter 2022 Conference Call. My name is Vikram and I will be your coordinator for the call today. 08/10/2022
Aspira Women's Health, Inc. (AWH) CEO Nicole Sandford on Q1 2022 Results - Earnings Call Transcript Aspira Women's Health, Inc. (NASDAQ:AWH ) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Nicole Sandford - President, Chief Executive Officer and Director Robert Beechey - Chief Financial Officer Michael Newton - Head, Commercial Conference Call Participants Brian Weinstein - William Blair & Company Ross Osborn - Cantor Fitzgerald & Co. Nicole Sandford Thank you, operator, and thank you to all of you for joining us today. I'll start with a business update before I hand the call over to Bob to review our Q1 financial performance. 05/11/2022
Aspira (AWH) Reports Q1 Loss, Misses Revenue Estimates Aspira (AWH) delivered earnings and revenue surprises of 0% and 5.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock? 05/11/2022
Aspira Women's Health to Announce First Quarter 2022 Financial Results and Host Conference Call on Wednesday, May 11 AUSTIN, Texas, April 29, 2022 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that the company will report its financial results for the first quarter ended March 31, 2022 before the market open on Wednesday, May 11, 2022. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 8:30am Eastern Time. Details for the call are below: 04/29/2022
Aspira Women's Health Inc. (AWH) CEO Nicole Sanford on Q4 2021 Results - Earnings Call Transcript Aspira Women's Health Inc. (AWH) CEO Nicole Sanford on Q4 2021 Results - Earnings Call Transcript 03/23/2022
Aspira (AWH) Reports Q4 Loss, Lags Revenue Estimates Aspira (AWH) delivered earnings and revenue surprises of 11.11% and 2.58%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? 03/23/2022
Aspira Women's Health to Announce Year End 2021 Financial Results and Host Conference Call on Wednesday, March 23 AUSTIN, Texas, March 15, 2022 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that the company will report its financial results for the year ended December 31, 2021 before the market open on Wednesday, March 23, 2022. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 8:30am Eastern Time. Details for the call are below: 03/15/2022
Best Penny Stocks To Buy For A Short Squeeze? 5 To Watch Today Short squeeze penny stocks to watch today. The post Best Penny Stocks To Buy For A Short Squeeze? 11/22/2021
Aspira Women's Health Inc. (AWH) CEO Valerie Palmieri on Q3 2021 Earnings Call Transcript Aspira Women's Health Inc. (AWH) CEO Valerie Palmieri on Q3 2021 Earnings Call Transcript 11/10/2021
Aspira (AWH) Reports Q3 Loss, Tops Revenue Estimates Aspira (AWH) delivered earnings and revenue surprises of -12.50% and 11.07%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock? 11/10/2021
5 Short Squeeze Penny Stocks To Buy For Under $5 Right Now 5 short squeeze penny stocks to buy for under $5. Are they worth the risk? 11/05/2021
Aspira Women's Health Inc. to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference AUSTIN, Texas, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that it will present at the Cantor Fitzgerald Virtual Global Healthcare Conference on Wednesday, September 29th, 2021. 09/21/2021
Aspira Women's Health Kicks Off Ovarian Cancer Awareness Month by Further Establishing Itself as a Thought Leader in Ovarian Cancer Signals Call to Action for Immediate Progress in Conquering Ovarian Cancer Signals Call to Action for Immediate Progress in Conquering Ovarian Cancer 09/09/2021
Aspira Women's Health's (AWH) CEO Valerie Palmieri on Q2 2021 Results - Earnings Call Transcript Aspira Women's Health's (AWH) CEO Valerie Palmieri on Q2 2021 Results - Earnings Call Transcript 08/12/2021
Aspira (AWH) Reports Q2 Loss, Tops Revenue Estimates Aspira (AWH) delivered earnings and revenue surprises of 0.00% and 5.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock? 08/12/2021
Analysts Estimate Aspira (AWH) to Report a Decline in Earnings: What to Look Out for Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 08/05/2021
Aspira Women's Health (AWH) is Oversold: Can It Recover? Aspira Women's Health (AWH) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. 07/15/2021
UPDATE -- Aspira Women's Health Inc. Announces Coverage for OVA1® in the AIM Specialty Health Laboratory Medicine Clinical Guidelines AUSTIN, Texas, July 08, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) today announced its OVA1® risk assessment test for ovarian cancer in women with pelvic masses is considered medically necessary according to AIM Specialty Health's Clinical Appropriateness Guidelines. AIM Specialty Health is a member of the Anthem Blue Cross Blue Shield family of companies and serves as a specialty benefits management company working with many of the nation's largest health care organizations. AIM's mission is to promote appropriate, safe, and affordable health care. As one of the nation's leading specialty benefits management firms, AIM helps improve the quality of care and reduces the cost for many of the most complex tests and treatments. 07/08/2021
Aspira Women's Health Inc. to Participate in the William Blair Growth Stock Conference AUSTIN, Texas, May 19, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that management will participate in and present at the William Blair Growth Stock Conference on June 1-3, 2021. Details for the event are below: 05/19/2021
Aspira Women's Health Inc. (AWH) CEO Valerie Palmieri on Q1 2021 Results - Earnings Call Transcript Aspira Women's Health Inc. (AWH) CEO Valerie Palmieri on Q1 2021 Results - Earnings Call Transcript 05/13/2021
Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates Aspira (AWH) delivered earnings and revenue surprises of 79.17% and 6.86%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock? 05/13/2021
Aspira Women's Health Reports First Quarter 2021 Financial Results Conference call scheduled for today, May13 at 4:30 p.m. ET Conference call scheduled for today, May13 at 4:30 p.m. ET 05/13/2021
Aspira Women's Health, Inc. Expands Leadership Team with Industry Veteran New Team Addition Is a Thought Leader in Reimbursement and Diagnostics New Team Addition Is a Thought Leader in Reimbursement and Diagnostics 05/11/2021
Earnings Preview: Aspira (AWH) Q1 Earnings Expected to Decline Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 05/06/2021
What Traders Can Expect From Small Caps in 2021 Below is a repost of an article from Benzina.com, which features Schaeffer's V.P. 03/28/2021
Aspira Women's Health Inc. (AWH) CEO Valerie Palmieri on Q4 2020 Results - Earnings Call Transcript Aspira Women's Health Inc. (AWH) CEO Valerie Palmieri on Q4 2020 Results - Earnings Call Transcript 03/25/2021
Aspira Women's Health Reports Fourth Quarter and Full Year 2020 Financial Results Conference Call scheduled for today, March 25th at 4:30 p.m. ET Conference Call scheduled for today, March 25th at 4:30 p.m. ET 03/25/2021
Analysts Estimate Aspira (AWH) to Report a Decline in Earnings: What to Look Out for Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. 03/18/2021
Aspira Women's Health Inc. Appoints Nicole Sandford to its Board of Directors AUSTIN, Texas, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced the appointment of Ms. Nicole Sandford to its Board of Directors. 02/22/2021
Aspira Women's Health, Inc. to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced management will participate and present in the 2021 BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place on February 17-19. Details for the event are below: 02/12/2021
Aspira Women's Health, Inc. to add NCCN Management Recommendations to its Proprietary Aspira GenetiX™ Clinical Report Aspira will incorporate Management Recommendations from the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in the Aspira GenetiX report Aspira will incorporate Management Recommendations from the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in the Aspira GenetiX report 02/10/2021
Aspira Women's Health Inc. Announces Pricing of $45 Million Public Offering of Common Stock AUSTIN, Texas, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women's health company focused on gynecologic disease, today announced the pricing of the previously announced underwritten public offering of 6,000,000 shares of its common stock at a price to the public of $7.50 per share. In addition, Aspira has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares are being offered by Aspira. 02/04/2021
Aspira Women's Health Inc. Announces Proposed Public Offering of Common Stock AUSTIN, Texas, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women's health company focused on gynecologic disease, today announced it has commenced an underwritten public offering of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Aspira is expected to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock being offered at the public offering price, less underwriting discounts and commissions. All of the shares will be offered by Aspira. 02/03/2021
Aspira Women's Health, Inc. to Participate in Virtual Investor Events Aspira to participate in the 10 th Annual LifeSci Advisors Corporate Access Event and Biotech Showcase™ from January 6 – 15 th , 2021 01/04/2021
Reviewing Aspira Women's Health (AWH) & Its Competitors Aspira Women's Health (NASDAQ: AWH) is one of 34 public companies in the “Diagnostic substances” industry, but how does it contrast to its competitors? We will compare Aspira Women's Health to related companies based on the strength of its institutional ownership, analyst recommendations, dividends, valuation, risk, profitability and earnings. Institutional & Insider Ownership 22.9% of […] 10/22/2020
COVID-19 Recovery Analysis: Spa Market \| Growing Wellness Tourism Industry to Boost the Market Growth \| Technavio The Global Spa Market will grow by $ 25.48 bn during 2020-2024 10/21/2020
UPDATE – Aspira Women’s Health Reports Second Quarter 2020 Financial Results Conference Call scheduled for today, August 13th at 4:30 p.m. ETAUSTIN, Texas, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“ASPIRA”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the second quarter ended June 30, 2020. “Despite late first quarter and second quarter challenges from COVID-19, we have delivered strong revenue and volume growth in the first half of 2020 as compared to the first half of 2019. In fact, our test volume was 12% higher in the first half of 2020 than in the same period in 2019. Delivering surgical triage results to physicians during this period of operating room rationing and backlog is essential,” said Valerie Palmieri, Chief Executive Officer of ASPIRA. “We are seeing patients return to their providers and began to see the corresponding volume restoration in the second quarter. OVANex™ and EndoCheck™ study site recruitment has also continued to improve.”Recent Corporate Highlights Year over Year Results – Second Quarter 2020 versus Second Quarter 2019: * OVA1 product volume decreased 21% to 2,458 units down from 3,129 units in the second quarter of last year * Product revenue decreased 32% to $743 thousand down from $1.1 million in the second quarter of last year * Total number of customers decreased by 18% compared to the second quarter of last year * New customers decreased by 56% compared to the second quarter of last year; * Total number of repeat customers were 85% in the second quarter of this year compared to 73% for the same period in the prior yearYear over Year Results – First Half 2020 versus First Half 2019: * OVA1 product volume increased 12% to 6,112 units up from 5,442 units in the first half of last year * Product revenue increased 4% to $1,953 thousand up from $1,879 thousand in the first half of last year * Total number of customers increased by 11% compared to the same period last year * New customers decreased by 25% compared to the same period last yearCOVID-19 TestingIn the second quarter of 2020, we began offering COVID-19 antibody testing and began preparations for offering COVID-19 antigen testing. Each test is or will be a part of our pre-surgical risk test offering, which also includes OVA1plus test, additional tumor proteins and genetics. * On June 10th, we announced we had completed laboratory validation of the antibody test, as well as laboratory validation of several additional oncology biomarkers. We are offering the Roche Elecsys Anti-SARS-Co-V-2 Assay which has a 99.81% sensitivity and 100% specificity. * Our planned offering of COVID-19 antigen testing has been postponed due to manufacturer instrumentation delays. We are now planning to offer this test in late third quarter or early fourth quarter 2020. Sales Contact and Virtual Ordering ProcessWe have developed and launched our Virtual Sales and Marketing Strategy. In addition, we have developed a process to facilitate physician on-line ordering to enable a more efficient virtual go to market strategy. We are refining our approach to include more targeted use of in-house sales personnel to enhance the effectiveness of sales representatives in the field and to accommodate practitioners who only allow limited onsite visits.Payroll Protection Program FinancingDuring the second quarter, we were granted a loan pursuant to the Payroll Protection Program (“PPP”) which was established under the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) which is being used primarily to fund payroll in the amount of approximately $1M. We are using the proceeds of the loan in a manner that we believe will qualify us for complete forgiveness of the principal of the loan under the terms of the CARES Act and the PPP. The Company plans to apply for loan forgiveness in the third quarter 2020.State of Connecticut FinancingWe previously announced a $4M loan from the State of Connecticut, $2M of which we received in 2016. The loan agreement provides that we will be eligible to receive the additional $2M based on target revenue and a revised target employment milestone. We achieved the target employment milestone as well as revenue targets. We have filed the required application and are awaiting final approval for the funding.Private PlacementIn July 2020, we sold shares of our common stock in a private placement generating approximately $11 million of gross proceeds prior to transaction costs. This financing, together with cash on hand at the end of the second quarter and expected additional funding from the State of Connecticut discussed above will enable us to execute on our product pipeline and continue to drive incremental growth and refinement of our commercial team. Second Quarter Financial Highlights: * Revenue on a per test performed basis for OVA1 revenue was $295 in the second quarter of 2020 compared to $324 in the first quarter of 2020. Included in the Q2 revenue and the average unit price were approximately $79 thousand in one-time revenue adjustments relating to prior periods which account for $32 per test of the decline. We are realizing a higher revenue per test for our new contract price from CIGNA, effective April 1, 2020, which was slightly offset by a temporary decrease in the mix of Medicare patients who, given their demographic, had reduced visits to doctors. * The number of OVA1 tests performed decreased 21% to 2,458 during the second quarter of 2020 compared to 3,129 for the same period in 2019. * Gross profit on OVA1 product revenue was $268 thousand (a 37% profit margin) for the second quarter of 2020 compared to $491 thousand for the same period in 2019 (a 45% profit margin). * Research and development expenses for the second quarter of 2020 were $380 thousand, an increase of $155 thousand compared to the same period in 2019. This increase was primarily due to the launch of clinical studies, the development of OVANex™, our third-generation serial monitoring product, as well as investments in bioinformatics and our cloud-based platform, ASPiRA GenetiX Technology Transfer. * Sales and marketing expenses for the second quarter of 2020 were $1.7M compared to $2.8M in the same period in 2019. This decrease was primarily due to reduced commission payments and personnel-related costs as well as reductions in consulting and travel due to the COVID-19 pandemic compared to those in the same period in 2019. * General and administrative expenses for the second quarter of 2020 were $1.9M compared to $1.5M for the same period in 2019. This increase was primarily due to an increase in headcount and personnel-related expenses as well as legal expenses. * The cash balance at June 30, 2020 was $10.9 million and cash utilization in the second quarter of 2020 was $3.3M, offset by cash received for the exercise of warrants of $5.1M and the receipt of the $1.0 million PPP loan. Cash utilization was lower than the preceding quarter primarily due to less expenses incurred as a result of COVID.Conference Call and WebcastASPIRA will host a call today at 4:30 p.m. Eastern Daylight Time to discuss results followed by a question and answer period.Thursday, August 13th @ 4:30pmET Domestic:877-407-4018 International:201-689-8471 Conference ID:13699543 Webcast: http://public.viavid.com/index.php?id=140750 About Aspira Women’s Health Inc. ASPIRA is transforming women’s health with the discovery, development and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1®plus combines our FDA-cleared products OVA1® and OVERA® to detect risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiXSM testing offers both targeted and comprehensive genetic testing options with a gynecologic focus. With over 10 years of expertise in ovarian cancer risk assessment ASPIRA has expertise in cutting-edge research to inform our next generation of products. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection and optimize treatment plans.Visit our website for more information about our products at www.aspirawh.com. Forward-Looking Statements This press release contains forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995, including statements regarding expected timing and receipt of proceeds from the State of Connecticut Department of Economic Development loan, expectations regarding the forgiveness of the PPP loan, anticipated use of capital and its effects and plans to begin offering COVID-19 antigen testing. These statements involve a number of risks and uncertainties. All statements other than statements of historical facts contained in this press release are forward-looking statements. Words such as “may,” “expects,” “intends,” “anticipates,” “believes,” “estimates,” “plans,” “seeks,” “could,” “should,” “continue,” “will,” “potential,” “projects” and similar expressions are intended to identify forward-looking statements. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions, including the risks and uncertainties inherent in business, including those described in the section entitled “Risk Factors” in ASPIRA’s Annual Report on Form 10-K for the year ended December 31, 2019, as supplemented by the section entitled “Risk Factors” in ASPIRA’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020. The events and circumstances reflected in ASPIRA’s forward-looking statements may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. 08/14/2020
Aspira Women's Health, Inc. (AWH) CEO Valerie Palmieri on Q2 2020 Results - Earnings Call Transcript Aspira Women's Health, Inc. (NASDAQ:AWH) Q2 2020 Earnings Conference Call August 13, 2020, 16:30 ET Company Participants Valerie Palmieri - CEO, President & Director Lesley Northrop - Global Medical Director, Genetic Services Robert Beechey - CFO Conference Call Participants Andrew Brackmann - William Blair & Company Presentation Operator Good afternoon, and welcome to Aspira Women's Health Second Quarter 2020 Conference Call. 08/13/2020
Aspira Women’s Health Reports Second Quarter 2020 Financial Results Conference Call scheduled for today, August 13th at 4:30 p.m. ETAUSTIN, Texas, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“ASPIRA”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the second quarter ended June 30, 2020.“Despite late first quarter and second quarter challenges from COVID-19, we have delivered strong revenue and volume growth in the first half of 2020 as compared to the first half of 2019. In fact, our test volume was 12% higher in the first half of 2020 than in the same period in 2019. Delivering surgical triage results to physicians during this period of operating room rationing and backlog is essential,” said Valerie Palmieri, Chief Executive Officer of ASPIRA. “We are seeing patients return to their providers and began to see the corresponding volume restoration in the second quarter. OVANex™ and EndoCheck™ study site recruitment has also continued to improve.”Recent Corporate Highlights Year over Year Results – Second Quarter 2020 versus Second Quarter 2019: * OVA1 product volume decreased 21% to 2,458 units down from 3,129 units in the second quarter of last year * Product revenue decreased 32% to $743 thousand down from $1.1 million in the second quarter of last year * Total number of customers decreased by 18% compared to the second quarter of last year * New customers decreased by 56% compared to the second quarter of last year; * Total number of repeat customers were 85% in the second quarter of this year compared to 73% for the same period in the prior yearYear over Year Results – First Half 2020 versus First Half 2019: * OVA1 product volume increased 12% to 6,112 units up from 5,442 units in the first half of last year * Product revenue increased 4% to $1,953 thousand up from $1,879 thousand in the first half of last year * Total number of customers increased by 11% compared to the same period last year * New customers decreased by 25% compared to the same period last yearCOVID-19 TestingIn the second quarter of 2020, we began offering COVID-19 antibody testing and began preparations for offering COVID-19 antigen testing. Each test is or will be a part of our pre-surgical risk test offering, which also includes OVA1plus test, additional tumor proteins and genetics. * On June 10th, we announced we had completed laboratory validation of the antibody test, as well as laboratory validation of several additional oncology biomarkers. We are offering the Roche Elecsys Anti-SARS-Co-V-2 Assay which has a 99.81% sensitivity and 100% specificity. * Our planned offering of COVID-19 antigen testing has been postponed due to manufacturer instrumentation delays. We are now planning to offer this test in late third quarter or early fourth quarter 2020. Sales Contact and Virtual Ordering ProcessWe have developed and launched our Virtual Sales and Marketing Strategy. In addition, we have developed a process to facilitate physician on-line ordering to enable a more efficient virtual go to market strategy. We are refining our approach to include more targeted use of in-house sales personnel to enhance the effectiveness of sales representatives in the field and to accommodate practitioners who only allow limited onsite visits.Payroll Protection Program FinancingDuring the second quarter, we were granted a loan pursuant to the Payroll Protection Program (“PPP”) which was established under the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) which is being used primarily to fund payroll in the amount of approximately $1M. We are using the proceeds of the loan in a manner that we believe will qualify us for complete forgiveness of the principal of the loan under the terms of the CARES Act and the PPP. The Company plans to apply for loan forgiveness in the third quarter 2020.State of Connecticut FinancingWe previously announced a $4M loan from the State of Connecticut, $2M of which we received in 2016. The loan agreement provides that we will be eligible to receive the additional $2M based on target revenue and a revised target employment milestone. We achieved the target employment milestone as well as revenue targets. We have filed the required application and are awaiting final approval for the funding.Private PlacementIn July 2020, we sold shares of our common stock in a private placement generating approximately $11 million of gross proceeds prior to transaction costs. This financing, together with cash on hand at the end of the second quarter and expected additional funding from the State of Connecticut discussed above will enable us to execute on our product pipeline and continue to drive incremental growth and refinement of our commercial team. Second Quarter Financial Highlights: * Revenue on a per test performed basis for OVA1 revenue was $295 in the second quarter of 2020 compared to $324 in the first quarter of 2020. Included in the Q2 revenue and the average unit price were approximately $79 thousand in one-time revenue adjustments relating to prior periods which account for $32 per test of the decline. We are realizing a higher revenue per test for our new contract price from CIGNA, effective April 1, 2020, which was slightly offset by a temporary decrease in the mix of Medicare patients who, given their demographic, had reduced visits to doctors. * The number of OVA1 tests performed decreased 21% to 2,458 during the second quarter of 2020 compared to 3,129 for the same period in 2019. * Gross profit on OVA1 product revenue was $268 thousand (a 37% profit margin) for the second quarter of 2020 compared to $491 thousand for the same period in 2019 (a 45% profit margin). * Research and development expenses for the second quarter of 2020 were $380 thousand, an increase of $155 thousand compared to the same period in 2019. This increase was primarily due to the launch of clinical studies, the development of OVANex™, our third-generation serial monitoring product, as well as investments in bioinformatics and our cloud-based platform, ASPiRA GenetiX Technology Transfer. * Sales and marketing expenses for the second quarter of 2020 were $1.7M compared to $2.8M in the same period in 2019. This decrease was primarily due to reduced commission payments and personnel-related costs as well as reductions in consulting and travel due to the COVID-19 pandemic compared to those in the same period in 2019. * General and administrative expenses for the second quarter of 2020 were $1.9M compared to $1.5M for the same period in 2019. This increase was primarily due to an increase in headcount and personnel-related expenses as well as legal expenses. * The cash balance at June 30, 2020 was $10.9 million and cash utilization in the second quarter of 2020 was $3.3M, offset by cash received for the exercise of warrants of $5.1M and the receipt of the $1.0 million PPP loan. Cash utilization was lower than the preceding quarter primarily due to less expenses incurred as a result of COVID.Conference Call and WebcastASPIRA will host a call today at 4:30 p.m. Eastern Daylight Time to discuss results followed by a question and answer period.Thursday, August 13th @ 4:30pmET Domestic:877-407-4018 International:201-689-8471 Conference ID:13699543 Webcast:http://public.viavid.com/index.php?id=138240 About Aspira Women’s Health Inc. ASPIRA is transforming women’s health with the discovery, development and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1®plus combines our FDA-cleared products OVA1® and OVERA® to detect risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiXSM testing offers both targeted and comprehensive genetic testing options with a gynecologic focus. With over 10 years of expertise in ovarian cancer risk assessment ASPIRA has expertise in cutting-edge research to inform our next generation of products. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection and optimize treatment plans.Visit our website for more information about our products at www.aspirawh.com. Forward-Looking Statements This press release contains forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995, including statements regarding expected timing and receipt of proceeds from the State of Connecticut Department of Economic Development loan, expectations regarding the forgiveness of the PPP loan, anticipated use of capital and its effects and plans to begin offering COVID-19 antigen testing. These statements involve a number of risks and uncertainties. All statements other than statements of historical facts contained in this press release are forward-looking statements. Words such as “may,” “expects,” “intends,” “anticipates,” “believes,” “estimates,” “plans,” “seeks,” “could,” “should,” “continue,” “will,” “potential,” “projects” and similar expressions are intended to identify forward-looking statements. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions, including the risks and uncertainties inherent in business, including those described in the section entitled “Risk Factors” in ASPIRA’s Annual Report on Form 10-K for the year ended December 31, 2019, as supplemented by the section entitled “Risk Factors” in ASPIRA’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2020. The events and circumstances reflected in ASPIRA’s forward-looking statements may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. 08/13/2020
Aspira Women’s Health, Inc. to Report Second Quarter 2020 Financial Results on August 13th AUSTIN, Texas, July 31, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it will report financial results for the second quarter ended June 30, 2020 on Thursday, August 13, 2020 after the market close, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.Thursday, August 13th @ 4:30pm ET Domestic:201-689-8472 International:877-407-4021 Conference ID:13706942 Webcast:http://public.viavid.com/index.php?id=140750 About Aspira Women’s Health Inc. Aspira Women’s Health, Inc. (formerly known as, Vermillion Inc., Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. ASPIRA is particularly focused on closing the ethnic disparity gap in ovarian cancer risk assessment and developing solutions for pelvic diseases such as pelvic mass risk assessment and endometriosis. OVA1® plus includes our FDA-cleared products, OVA1® and OVERA® to detect risk of ovarian malignancy in women with adnexal masses. ASPIRA GenetiX™ testing offers both targeted and comprehensive genetic testing options with a gynecologic focus. With over 10 years of expertise in ovarian cancer risk assessment, ASPIRA is delivering a portfolio of pelvic mass products over a patient’s lifetime with our cutting-edge research. The next generation of products in development are OVANEX™ and EndoCheck™. Visit our website for more information at www.aspirawh.com.Investor Relations Contact:Ashley R. Robinson LifeSci Advisors, LLC Tel 617-430-7577 Arr@lifesciadvisors.com 07/31/2020
Insider Buying: Jack Schuler Just Spent US$8.0m On Aspira Women's Health Inc. (NASDAQ:AWH) Shares Those following along with Aspira Women's Health Inc. (NASDAQ:AWH) will no doubt be intrigued by the recent purchase... 07/08/2020
Aspira Women’s Health Inc. Announces Equity Financing of Approximately $11 Million The closing of the private placement is expected to occur on July 6, 2020, subject to customary closing conditions. At the closing, ASPIRA will receive approximately $11 million in gross proceeds, before transaction costs. ASPIRA intends to use the net proceeds from the private placement for sales and marketing, working capital and other general corporate purposes, including investing in additional key strategic hires and product portfolio expansion. 07/01/2020
Aspira Women’s Health, Inc. Announces First Patient Enrolled in Prospective OVANex Study for Benign Pelvic Mass Monitoring Aspira Women’s Health, Inc. (AWH), a bioanalytical-based women’s health company, today announced the first patient enrolled in a national clinical study of benign pelvic mass management. The study will enroll over 1,000 women for assessing ovarian cancer risk in women who have an adnexal mass and a high probability for developing the disease. 06/29/2020
Fairfax Financial Holdings' (Prem Watsa) Annual Chairman Letter To Shareholders 2017 03/13/2018
20 Stocks Moving In Friday's Pre-Market Session 07/07/2017
AXIS Capital to Buy Novae & Consolidate Lloyd's Presence 07/06/2017
Allied World Assurance Company Holdings Merger Deal with Fiarfax Financial Extended to July 5 from June 30th 07/03/2017
Merger Monday: 9 M&A Firecrackers Ahead Of Market Holiday 07/03/2017
Allied World Accepts Final Fairfax Financial Exchange Ratio 06/30/2017
Carlson Capital L P Buys Mobileye NV, Macy's Inc, VCA Inc, Sells St Jude Medical Inc, Endurance ... 05/22/2017
Carlson Capital L P Buys Mobileye NV, Macy's Inc, VCA Inc, Sells St Jude Medical Inc, Endurance ... 05/17/2017
Alpine Partners VI, LLC Buys Mobileye NV, VCA Inc, Allied World Assurance Co Holdings AG, Sells ... 05/15/2017
Gabelli Securities, Inc. Buys VCA Inc, Mobileye NV, Reynolds American Inc, Sells St Jude ... 05/04/2017
Allied World Reports Q1 Adj. $0.53 vs $0.68 Est., Sales $639.183M vs $652.798 In Same Qtr. Last Year 04/26/2017
Prem Watsa's Place in the Benjamin Graham Universe 03/24/2017
Allied World Sharholders Approve Special Dividend $5/Share In Connection With Merger Transaction 03/22/2017
Stocks Steven Cohen Continues to Buy 03/02/2017
Allied World (AWH) Misses Earnings, Beats Revenues in Q4 02/02/2017
Allied World Assurance Company Reports Q4 Operating EPS $0.48, Revenues $537.982M 02/01/2017
Allied World Assurance misses by $0.15, misses on revenue 02/01/2017
Allied World Assurance Spikes to High of $53.58 on Volume 01/26/2017
7 High-Yield Companies With High Profitability 01/20/2017
Recent Declines Are Opportunity to Buy Fairfax Financial Holdings 01/17/2017
Top Insurance Stocks Set Up For New Buy Points 01/10/2017
JP Morgan Downgrades Allied World Assurance Company Holdings, AG (Switzerland) to Neutral 01/06/2017
'Canada's Warren Buffett' Prem Watsa Praises Trump, Forecasts Stock Pickers' Market 12/22/2016
JMP Securities Downgrades Allied World Assurance to Market Perform 12/21/2016
BMO Capital Upgrades Allied World Assurance to Market Perform 12/21/2016
15 Biggest Mid-Day Gainers For Monday 12/19/2016
Fairfax Financial to Acquire Allied World for $54/Share in Cash and Stock 12/18/2016
Allied World Assurance declares $0.26 dividend 12/05/2016
Macquarie Downgrades Allied World Assurance Company Holdings, AG (Switzerland) to Neutral 12/02/2016
Allied World Assurance Company Holdings' (AWH) CEO Scott Carmilani on Q3 2016 Results - Earnings Call Transcript 11/01/2016
Allied World Reports Q3 EPS $0.77 vs. Est. $0.60, Rev. $647.15M vs. Est. $612M 10/31/2016
Reversals Off New Highs Point To Weak Market 10/11/2016
6 Stocks With Growing Yield and Strong Returns 10/10/2016
Allied World Pops to High of $41.25 on Volume 10/04/2016
10 Notable Stocks Trading Ex-Dividend Friday, September 16 09/15/2016
Allied World Assurance declares $0.26 dividend 09/08/2016
15 Biggest Mid-Day Gainers For Wednesday 07/20/2016
Allied World Assurance Reports Q2 Operating EPS $0.91 07/19/2016
Notable earnings after Tuesday's close 07/18/2016
The Impact Of Different Weighting Methods On My Dividend Portfolio 07/07/2016
JP Morgan Initiates Coverage on Arrowhead Gold at Neutral 06/28/2016
Allied World Assurance Launches Accounts Receivable Insurance in US 06/15/2016
Allied World Assurance declares $0.26 dividend 06/08/2016
Dividend Contenders: 18 Increases Expected By July 31 05/17/2016
Allied World Assurance Company Holdings' (AWH) CEO Scott Carmilani on Q1 2016 Results - Earnings Call Transcript 04/20/2016
Allied World Assurance Corp Approves New 2-Year $500M Buyback, Was Announced Earlier Today 04/19/2016
Notable earnings after Tuesday's close 04/18/2016
Benzinga's Top Downgrades 03/28/2016
Allied World Assurance declares $0.26 dividend 03/03/2016
AmTrust: Investment Income Can't Keep Up With Workers' Compensation Growth 02/27/2016
Allied World Assurance Co Holdings' (AWH) CEO Scott Carmilani on Q4 2015 Results - Earnings Call Transcript 02/04/2016
Allied World Assurance Reports Q4 Ops EPS $0.47 Vs Est $0.59 02/03/2016
Piper Jaffray Initiates Coverage on Allied World Assurance at Overweight, Announces $44.00 PT 12/10/2015
Allied World's (AWH) CEO Scott Carmilani on Q3 2015 Results - Earnings Call Transcript 10/22/2015
Allied World Reports Q3 Loss $0.57 Vs Prior $0.31 10/21/2015
Arrowhead Gold to Acquire Nuvo Energy Grid Inc. 10/16/2015
Shares of Allied World Assurance Resume, Now Trading at $39.09 09/18/2015
Daily Dividend: Company's Going Ex-Dividend Friday Of Next Week 09/11/2015
Allied World Assurance declares $0.26 dividend 09/08/2015
Allied World Assurance Co Holdings' (AWH) CEO Scott Carmilani on Q2 2015 Results -- Earnings Call Transcript 07/23/2015
Allied World Assurance EPS of $0.10 07/22/2015
AXIS Capital Counting on PartnerRe Merger, Costs Trouble - Analyst Blog 07/08/2015
Allied World (AWH) Hits 52-Week High on FrameWRX Launch - Analyst Blog 06/26/2015
9 Dividend Increases, June 1-12, 2015 06/15/2015
Allied World Assurance declares $0.26 dividend 06/10/2015
Will Allied World Assurance (AWH) Crush Estimates at Its Next Earnings Report? - Tale of the Tape 06/04/2015
Should You Add Allied World (AWH) to Your Portfolio Now? - Analyst Blog 06/03/2015
Allied World Hits 52-Week High on Solid Q1 & Dividend Hike - Analyst Blog 05/18/2015
Allied World Offers A Healthy Balance Sheet, But Market Conditions Are Tough 05/15/2015
Allied World Increases Annual Dividend From $0.90 To $1.04/Share 05/04/2015
Why You Shouldn't Bet Against Allied World Assurance (AWH) Stock - Tale of the Tape 04/28/2015
Allied World's (AWH) CEO Scott Carmilani on Q1 2015 Results - Earnings Call Transcript 04/23/2015
Allied World Assurance Company Holding Reports Q1 EPS $0.93 Vs Est $0.84, Sales $659M Vs Est $577.35M 04/22/2015
Barclays Reinstates Equal-weight on Allied World Assurance, Announces $42.00 PT 04/17/2015
Berkshire Hathaway to Acquire 8.7% Stake in Axalta Coating - Analyst Blog 04/08/2015
Berkshire Hathaway Unit in Hot Water for Unfair Lending - Analyst Blog 04/07/2015
ACE Limited Closes Fireman's Fund Acquisition, Stock Up - Analyst Blog 04/06/2015
Progressive Closes ARX Buyout, Boosts Bundled Offering - Analyst Blog 04/02/2015
Allied World (AWH) Expands Operations in Southeast Asia - Analyst Blog 04/01/2015
RenaissanceRe Banks on Acquisitions, Cat Losses a Drag - Analyst Blog 03/31/2015
Maiden Holdings Hits 52-Week High on Solid Q4 Results - Analyst Blog 03/26/2015
Keefe, Bruyette & Woods Assumes Coverage On Allied World Assurance Company On Positive Outlook 03/23/2015
RenaissanceRe Issues $300M Senior Notes Due 2025 - Analyst Blog 03/20/2015
3 Stocks to Benefit From a Fed Rate Hike - Stocks in the News 03/19/2015
Greenlight Capital Downgraded on Lackluster Results in Q4 - Analyst Blog 03/18/2015
Travelers Scales 52-Week High on Solid Performance in Q4 - Analyst Blog 03/17/2015
A.M. Best Affirms Validus Holdings' Ratings, Shares Constant - Analyst Blog 03/16/2015
First American Expands Title Insurance, Buys TitleVest - Analyst Blog 03/13/2015
ProAssurance's Capital Actions Look Good, Retentions Fall - Analyst Blog 03/11/2015
eHealth Now a Strong Sell: Is Wider Q4 Loss Responsible? - Analyst Blog 03/10/2015
Brown & Brown Enters ASR Program Worth $100 Million - Analyst Blog 03/09/2015
Third Point Re Down to Strong Sell on Dismal Q4 Earnings - Analyst Blog 03/06/2015
Allied World Assurance declares $0.225 dividend 03/04/2015
Mercury General Down Post Rating Affirmation by A.M. Best - Analyst Blog 03/03/2015
Allied World Announces Retirement of Scott Hunter from the Board of Directors 03/02/2015
RLI Corp's Premium Improvement Initiatives Look Promising - Analyst Blog 02/25/2015
Chubb Leads by Virtue of Superior Underwriting Acumen - Analyst Blog 02/24/2015
ProAssurance Corp (PRA): What's in Store for Q4 Earnings? - Analyst Blog 02/23/2015
Will Allied World Assurance Company Holdings, AG (AWH) Crush Estimates at Its Next Earnings Report? - Tale of the Tape 02/19/2015
Reinsurance Group Hits 52-Week High on Solid Q4 Earnings - Analyst Blog 02/18/2015
American Financial Hits 52-Week High on Solid Q4 Earnings - Analyst Blog 02/17/2015
First American Financial (FAF) in Focus: Stock Jumps 5.3% - Tale of the Tape 02/13/2015
Everest Re at 52-Week High on Q4 Earnings Outperformance - Analyst Blog 02/09/2015
McKesson Corporation Leads The 20 Best Value Bond Trades With Maturities Of 1 Year Or More 02/06/2015
Allied World Assurance Holdings, AG (AWH) Q4 2014 Results - Earnings Call Transcript 02/05/2015
Allied World Assurance Company Holdings Reports Q4 EPS $1.33 Vs Est $0.70 May Not COmpare, Revs $608.2M Vs Est $597.05M 02/04/2015
Why Allied World Assurance (AWH) Stock Might be a Great Pick - Tale of the Tape 01/30/2015
Europe: A Filter For 17 Interesting Stocks 01/15/2015
Allied World Closes Buyout of Latin American Underwriters - Analyst Blog 01/13/2015
XL Group in Talks to Buy Catlin, Increases Alternative Capital - Analyst Blog 12/18/2014
Progressive to Insure Home & Auto with ARX Majority Stake - Analyst Blog 12/17/2014
Kemper Boosts Auto Insurance with Alliance United Buyout - Analyst Blog 12/12/2014
BMO Capital Downgrades Allied World Assurance Company Holdings, AG to Market Perform, Maintains $39.00 PT 12/08/2014
ProAssurance (PRA) Raises Dividend & Approves Buyback - Analyst Blog 12/04/2014
Allied World to Strengthen Specialty with LAU Acquisition - Analyst Blog 11/12/2014
Allied World To Acquire Latin American Underwriters, No Terms Disclosed 11/10/2014
Arrowhead Commences Trading on the Canadian Securities Exchange, Undertakes Shares for Debt ... 10/30/2014
W.R. Berkley Beats Earnings, Revenues on High Premiums - Analyst Blog 10/24/2014
Everest Re Q3 Earnings Beat Estimates, Top Line Grows - Analyst Blog 10/23/2014
Allied World Assurance Company Holdings, AG Reports Q3 EPS of $0.61 vs $0.74 Est 10/22/2014
Is Allied World (AWH) Worth Adding to Your Portfolio? - Analyst Blog 10/21/2014
Will Chubb Corp (CB) Beat Q3 Earnings on Premium Growth? - Analyst Blog 10/20/2014
3 P&C Insurers that Assure Upbeat Earnings - Earnings ESP 10/16/2014
Allied World Arm to Expand Operations in Southeast Asia - Analyst Blog 08/22/2014
Allied World Assurance Reports Purchase of Hong Kong, Sinagpore Operations of RSA for $215M 08/21/2014
Chubb Q2 Earnings Miss on Elevated Claims, Guidance Trimmed - Analyst Blog 07/25/2014
Allied World Q2 Earnings Miss on Lower Underwriting Income - Analyst Blog 07/24/2014
Allied World Assurance Company Holdings, AG Reports Q2 EPS of $1.51 Which May Not Compare $0.78 Est; Revenue of $659.30M Which May Not Compare $564.70M Est 07/23/2014

Unlock

AWH Ratings Summary

AWH Quant Ranking